Showing results (1351-1360 of 6,507) with videos related to
Sort By:
Pageof 651
Cancer Immunology, Immunotherapy : CII|November 13, 2012
TRAIL suppresses tumor growth in mice by inducing tumor-infiltrating CD4(+)CD25 (+) Treg apoptosisZhijuan Diao, Juan Shi, Jieqing Zhu, et al.Cancer Immunology, Immunotherapy : CII|August 1, 1997
Quantitative analysis of cytokine mRNA expression in peripheral blood mononuclear cells following treatment with interleukin-2M Adachi, H Inoue, S Arinaga, et al.Cancer Immunology, Immunotherapy : CII|August 1, 1997
A phase II study of interferon alpha and low-dose subcutaneous interleukin-2 in advanced renal cell carcinomaA Piga, P Giordani, A Quattrone, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1993
Cellular and cytokine responses of the human central nervous system to intracranial administration of tumor necrosis factor alpha for the treatment of malignant gliomasM Tada, Y Sawamura, S Sakuma, et al.Cancer Immunology, Immunotherapy : CII|March 2, 2023
Clinicopathological significance of peritumoral alveolar macrophages in patients with resected early-stage lung squamous cell carcinomaYu Tanaka, Tokiko Nakai, Ayako Suzuki, et al.Cancer Immunology, Immunotherapy : CII|August 11, 2022
Soluble CD163: a novel independent prognostic biomarker in patients with metastatic renal cell carcinomaKasper Munch Lauridsen, Marianne Hokland, Sinan Al-Karradi, et al.Cancer Immunology, Immunotherapy : CII|August 17, 2022
Protein Expression of immune checkpoints STING and MHCII in small cell lung cancerDavid Dora, Christopher Rivard, Hui Yu, et al.Cancer Immunology, Immunotherapy : CII|November 7, 2022
Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cellsAlistair L J Symonds, Tizong Miao, Zabreen Busharat, et al.Cancer Immunology, Immunotherapy : CII|August 31, 2021
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuationMarco Russano, Alessio Cortellini, Raffaele Giusti, et al.Cancer Immunology, Immunotherapy : CII|August 4, 2022
Anti-mesothelin CAR-T immunotherapy in patients with ovarian cancerJiannan Chen, Jianhua Hu, Lili Gu, et al.Pageof 651